期刊
THORAX
卷 77, 期 12, 页码 1176-1186出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2021-218083
关键词
Paediatric Lung Disaese
资金
- Helmholtz Foundation [NWG VH--NG--829]
- Helmholtz Zentrum Muenchen, Germany
- International Research Group 'Role of BMP signalling' [01KI07110]
- Helmholtz Foundation (German Ministry of Education and Health (BMBF)
- German Centre for Lung Research (DZL, German Ministry of Education and Health (BMBF)
- German Science and Research Organisation (DFG) [GRK2338]
- Progress Study Group (BMBF) [01KI1010C, 01KI1010I]
We identified impaired BMP signaling as a hallmark of early vascular disease in the injured neonatal lung and outlined its promising potential as a future biomarker or therapeutic target.
Introduction Chronic lung disease, that is, bronchopulmonary dysplasia (BPD) is the most common complication in preterm infants and develops as a consequence of the misguided formation of the gas-exchange area undergoing prenatal and postnatal injury. Subsequent vascular disease and its progression into pulmonary arterial hypertension critically determines long-term outcome in the BPD infant but lacks identification of early, disease-defining changes. Methods We link impaired bone morphogenetic protein (BMP) signalling to the earliest onset of vascular pathology in the human preterm lung and delineate the specific effects of the most prevalent prenatal and postnatal clinical risk factors for lung injury mimicking clinically relevant conditions in a multilayered animal model using wild-type and transgenic neonatal mice. Results We demonstrate (1) the significant reduction in BMP receptor 2 (BMPR2) expression at the onset of vascular pathology in the lung of preterm infants, later mirrored by reduced plasma BMP protein levels in infants with developing BPD, (2) the rapid impairment (and persistent change) of BMPR2 signalling on postnatal exposure to hyperoxia and mechanical ventilation, aggravated by prenatal cigarette smoke in a preclinical mouse model and (3) a link to defective alveolar septation and matrix remodelling through platelet derived growth factor-receptor alpha deficiency. In a treatment approach, we partially reversed vascular pathology by BMPR2-targeted treatment with FK506 in vitro and in vivo. Conclusion We identified impaired BMP signalling as a hallmark of early vascular disease in the injured neonatal lung while outlining its promising potential as a future biomarker or therapeutic target in this growing, high-risk patient population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据